Market Update (NYSE:BSX): Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

[PR Newswire] – MARLBOROUGH, Mass., Sept. 23, 2014 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has initiated the REPRISE III clinical trial, a pivotal study to evaluate the safety and effectiveness of the . . . → Read More: Market Update (NYSE:BSX): Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System Similar Articles: Market Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific To Participate In 2014 Bank Of America Merrill Lynch Global Healthcare Conference Market Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents Stock Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs